a number of randomized studies have shown the efficacy of nimodipine , administered either orally or intravenously , for the prevention of vasospasm and its clinical consequences in patients with subarachnoid haemorrhage following rupture of an intracranial aneurysm .
C0028094
nimodipine
C0038525
subarachnoid haemorrhage